Ali Rihani
Impact in
- Cancer Research top 10%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Neurology top 10%
- Neuroblastoma Research and Treatments
Papers in
-
- Neuroblastoma Research and Treatments 6
- Oncology 5
- Cancer-related Molecular Pathways 5
- Co-authors
- Jo Vandesompele (14 shared papers)Frank Speleman (12 shared papers)Tom Van Maerken (11 shared papers)Anne De Paepe (5 shared papers)Alan Van Goethem (4 shared papers)Steve Lefever (3 shared papers)Jean‐Christophe Marine (2 shared papers)Nurten Yigit (2 shared papers)
In The Last Decade
Ali Rihani
21 papers receiving 969 citations
Peers
Comparison fields: 5 of 86
- Cancer Research 211
- Neurology 179
- Oncology 142
- Molecular Biology 299
- Physiology 14
Countries citing papers authored by Ali Rihani
This map shows the geographic impact of Ali Rihani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ali Rihani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ali Rihani more than expected).
Fields of papers citing papers by Ali Rihani
This network shows the impact of papers produced by Ali Rihani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ali Rihani. The network helps show where Ali Rihani may publish in the future.
Co-authors
The 25 scholars most cited alongside Ali Rihani, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 251 | |
| 2 | 2010 | 125 | |
| 3 | 2009 | 104 | |
| 4 | 2014 | 79 | |
| 5 | 2011 | 65 | |
| 6 | 2009 | 57 | |
| 7 | 2013 | 43 | |
| 8 | 2014 | 41 | |
| 9 | 2015 | 40 | |
| 10 | 2015 | 33 | |
| 11 | 2011 | 30 | |
| 12 | 2019 | 30 | |
| 13 | 2014 | 20 | |
| 14 | 2020 | 15 | |
| 15 | 2013 | 12 | |
| 16 | 2018 | 11 | |
| 17 | 2020 | 11 | |
| 18 | 2021 | 5 | |
| 19 | 2014 | 4 | |
| 20 | Selective inhibition of the p53–MDM2 interaction by nutlin drugs: a new therapeutic perspective for neuroblastoma | 2013 | 1 |
About Ali Rihani
Ali Rihani is a scholar working on Neurology, Oncology, Cancer Research, Molecular Biology and Genetics, having authored 22 papers that have together received 978 indexed citations. Recurring topics across this work include Neuroblastoma Research and Treatments (6 papers), Cancer-related Molecular Pathways (5 papers), Molecular Biology Techniques and Applications (5 papers), MicroRNA in disease regulation (2 papers), Genomic variations and chromosomal abnormalities (1 paper), Estrogen and related hormone effects (1 paper), Protein Degradation and Inhibitors (1 paper) and Influenza Virus Research Studies (1 paper). The work is most often cited by research in Cancer Research (211 citations), Neurology (179 citations), Oncology (142 citations), Molecular Biology (299 citations) and Physiology (14 citations). Ali Rihani has collaborated with scholars based in Belgium, Sweden and Germany. Frequent co-authors include Jo Vandesompele, Frank Speleman, Tom Van Maerken, Anne De Paepe, Alan Van Goethem, Steve Lefever, Jean‐Christophe Marine, Nurten Yigit, Gert Van Peer and Pieter Mestdagh. Their work appears in journals such as Scientific Reports, PLoS ONE, Molecular Cancer Therapeutics, Nature Methods and Pediatric Blood & Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.